Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Aug;94(8):1092-8.
doi: 10.1177/0022034515589314. Epub 2015 Jun 15.

Kinetic-dependent Killing of Oral Pathogens with Nitric Oxide

Affiliations

Kinetic-dependent Killing of Oral Pathogens with Nitric Oxide

C J Backlund et al. J Dent Res. 2015 Aug.

Abstract

Nitric oxide (NO)-releasing silica nanoparticles were synthesized via the co-condensation of tetramethyl orthosilicate with aminosilanes and subsequent conversion of secondary amines to N-diazeniumdiolate NO donors. A series of ~150 nm NO-releasing particles with different NO totals and release kinetics (i.e., half-lives) were achieved by altering both the identity and mol% composition of the aminosilane precursors. Independent of identical 2 h NO-release totals, enhanced antibacterial action was observed against the periodontopathogens Aggregatibacter actinomycetemcomitans and Porphyromonas gingivalis with extended NO-release kinetics at pH 7.4. Negligible bactericidal effect was observed against cariogenic Streptococcus mutans at pH 7.4, even when using NO-releasing silica particles with greater NO-release totals. However, antibacterial activity was observed against S. mutans at lower pH (6.4). This result was attributed to more rapid proton-initiated decomposition of the N-diazeniumdiolate NO donors and greater NO-release payloads. The data suggest a differential sensitivity to NO between cariogenic and periodontopathogenic bacteria with implications for the future development of NO-releasing oral care therapeutics.

Keywords: Aggregatibacter actinomycetemcomitans; N-diazeniumdiolate; Porphyromonas gingivalis; dental caries; periodontal disease; silica.

PubMed Disclaimer

Conflict of interest statement

The corresponding author declares a competing financial interest. Mark Schoenfisch is a co-founder, is a member of the board of directors, and maintains a financial interest in Novan Therapeutics, Inc. Novan is commercializing macromolecular nitric oxide storage and release vehicles for dermatological indications. The authors declare no further potential conflicts of interest with respect to the authorship and/or publication of this article.

Figures

Figure 1.
Figure 1.
Bactericidal efficacy of (A) 50 mol% 3-methylaminopropyltrimethoxysilane (MAP3) particles, (B) 60 mol% N-(6-aminohexyl)aminopropyltrimethoxysilane (AHAP3) particles, and (C) 80 mol% N-(2-aminoethyl)-3-aminopropyltrimethoxysilane (AEAP3) particles against Aggregatibacter actinomycetemcomitans in Tris–phosphate-buffered saline (PBS) (pH 7.4) after 2 h. Bactericidal efficacy of (D) 50 mol% MAP3 particles, (E) 60 mol% AHAP3 particles, and (F) 80 mol% AEAP3 particles against Porphyromonas gingivalis in Tris-PBS (pH 7.4) after 2 h. Nitric oxide (NO)–releasing material denoted by rectangles (■) and non-NO-releasing controls denoted by circles (●). Error bars signify standard deviation of the mean bacterial viability (colony-forming units [CFU]/mL). For all measurements, n = 3 or more pooled experiments.
Figure 2.
Figure 2.
Cytotoxicity of nitric oxide (NO)–releasing and control silica particles against HGF-1 human gingival fibroblasts at the greatest MBC2h values to kill periodontopathogens. The concentrations to kill Aggregatibacter actinomycetemcomitans were 8, 32, and 48 mg/mL for 80 mol% N-(2-aminoethyl)-3-aminopropyltrimethoxysilane (AEAP3), 60 mol% N-(6-aminohexyl)aminopropyltrimethoxysilane (AHAP3), and 50 mol% 3-methylaminopropyltrimethoxysilane (MAP3), respectively. Viability measured as metabolic activity versus untreated cells. Error bars represent standard deviation of the mean. For all values, n = 4 replicate measurements. Asterisk indicates P < 0.05 using 2-tailed Student’s t test.
Figure 3.
Figure 3.
Confocal microscopy images of Aggregatibacter actinomycetemcomitans exposed to 1 mg/mL nitric oxide (NO)–releasing silica nanoparticles (50 mol% 3-methylaminopropyltrimethoxysilane [MAP3], 60 mol% N-(6-aminohexyl)aminopropyltrimethoxysilane [AHAP3], and 80 mol% N-(2-aminoethyl)-3-aminopropyltrimethoxysilane [AEAP3]) after (A) 30 min, (B) 60 min, and (C) 120 min of particle exposure. DAF-2 fluorescence is depicted as black in this image for clarity and represents intracellular NO concentrations.
Figure 4.
Figure 4.
Confocal microscopy images of Streptococcus mutans exposed to 0.25 mg/mL 70 mol% 3-methylaminopropyltrimethoxysilane (MAP3) nitric oxide–releasing silica nanoparticles at (A) 40 min, (B) 60 min, and (C) 90 min after particle exposure. DAF-2 fluorescence is depicted as black in the images for clarity. Numbers in images represent the relative summed signal intensities normalized to the fluorescence intensity at 0 min and pH 7.4.

References

    1. Allaker R, Silva Mendez L, Hardie J, Benjamin N. 2001. Antimicrobial effect of acidified nitrite on periodontal bacteria. Oral Microbiol Immunol. 16(4):253–256. - PubMed
    1. Aoki W, Kuroda K, Ueda M. 2012. Next generation of antimicrobial peptides as molecular targeted medicines. J Biosci Bioeng. 114(4):365–370. - PubMed
    1. Backlund CJ, Sergesketter AR, Offenbacher S, Schoenfisch MH. 2014. Antibacterial efficacy of exogenous nitric oxide on periodontal pathogens. J Dent Res. 93(11):1089–1094. - PMC - PubMed
    1. Barbe C, Bartlett J, Kong L, Finnie K, Lin HQ, Larkin M, Calleja S, Bush A, Calleja G. 2004. Silica particles: a novel drug-delivery system. Adv Mater. 16(21):1959–1966.
    1. Bogdan C. 2001. Nitric oxide and the immune response. Nat Immunol. 2(10):907–916. - PubMed

Publication types

MeSH terms